Some strange news from Nikon today: the company published a press release detailing some decisions made at a meeting of the Board of Directors that was held today. The directors were discussing some proposed amendments to the company’s Articles of Incorporation that will be discussed at the general shareholders meeting on June 28th. Under the section that spells out Nikon’s business activities, they’re proposing the following amendment:
Manufacture and sale of pharmaceuticals, quasi-pharmaceutical products and cosmetics;
Unless we’re reading this press release incorrectly, it seems to indicate that Nikon is planning to manufacture and sell pharmaceuticals and cosmetics.
Here’s a screenshot of the press release that shows the proposed modifications: